These GlyCAFs upregulate the expression of GLUT1‐dependent CXCL16, which prevents CD8+ T cells from contacting and infiltrating tumor cells, leading to immune evasion and resistance to immunotherapy [212]. The gene discussed is CD8A; the disease is neoplasm.